FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999164400> ?p ?o ?g. }

• W1999164400 endingPage "31" @default.
• W1999164400 startingPage "22" @default.
• W1999164400 abstract "Multiple myeloma (MM) is consistently preceded by its pre-malignant states, monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering multiple myeloma (SMM). By definition, precursor conditions do not exhibit end-organ disease (anemia, hypercalcemia, renal failure, skeletal lytic lesions, or a combination of these). However, new imaging methods are demonstrating that some patients in the MGUS or SMM category are exhibiting early signs of MM. Although MGUS/SMM patients are currently defined as low-risk versus high-risk based on clinical markers, we currently lack the ability to predict the individual patient's risk of progression from MGUS/SMM to MM. Given that the presence of gross lytic bone lesions is a hallmark of MM, it is reasonable to believe that less severe bone changes defined by more sensitive imaging may be predictive of MM progression. Indeed, since bone disease is such an essential aspect of MM, imaging techniques directed at the detection of early bone lesions, have the potential to become increasingly more useful in the setting of MGUS/SMM. Current guidelines for the radiological assessment of MM still recommend the traditional skeletal survey, although its limitations are well documented, especially in early phases of the disease when radiographs can significantly underestimate the extent of bone lesions and bone marrow involvement. Newer, more advanced imaging modalities, with higher sensitivities, including whole-body low-dose computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are being employed. Also various imaging techniques have been used to provide an assessment of bone involvement and identify extra-osseous disease. This review emphasizes the current state of the art and emerging imaging methods, which may help to better define high-risk versus low-risk MGUS/SMM. Ultimately, improved imaging could allow more tailored clinical management, and, most likely play an important role in the development of future treatment strategies for high-risk precursor disease." @default.
• W1999164400 created "2016-06-24" @default.
• W1999164400 creator A5000683497 @default.
• W1999164400 creator A5058021865 @default.
• W1999164400 creator A5067251812 @default.
• W1999164400 creator A5082004555 @default.
• W1999164400 creator A5082080836 @default.
• W1999164400 date "2011-01-01" @default.
• W1999164400 modified "2023-10-15" @default.
• W1999164400 title "Molecular Imaging in Myeloma Precursor Disease" @default.
• W1999164400 cites W1823421108 @default.
• W1999164400 cites W1968480678 @default.
• W1999164400 cites W1970183845 @default.
• W1999164400 cites W1974069649 @default.
• W1999164400 cites W1979542762 @default.
• W1999164400 cites W1982972117 @default.
• W1999164400 cites W1983512569 @default.
• W1999164400 cites W1984259729 @default.
• W1999164400 cites W1984747044 @default.
• W1999164400 cites W1988876144 @default.
• W1999164400 cites W1989213522 @default.
• W1999164400 cites W1996697509 @default.
• W1999164400 cites W2000432684 @default.
• W1999164400 cites W2003659586 @default.
• W1999164400 cites W2004810624 @default.
• W1999164400 cites W2006382315 @default.
• W1999164400 cites W2030894550 @default.
• W1999164400 cites W2031157863 @default.
• W1999164400 cites W2041811430 @default.
• W1999164400 cites W2050148787 @default.
• W1999164400 cites W2050281367 @default.
• W1999164400 cites W2051272359 @default.
• W1999164400 cites W2056005021 @default.
• W1999164400 cites W2074174622 @default.
• W1999164400 cites W2076775805 @default.
• W1999164400 cites W2088968628 @default.
• W1999164400 cites W2093393264 @default.
• W1999164400 cites W2101281436 @default.
• W1999164400 cites W2103293050 @default.
• W1999164400 cites W2103746869 @default.
• W1999164400 cites W2106462703 @default.
• W1999164400 cites W2107413864 @default.
• W1999164400 cites W2108529034 @default.
• W1999164400 cites W2119047576 @default.
• W1999164400 cites W2121843691 @default.
• W1999164400 cites W2140978366 @default.
• W1999164400 cites W2142885598 @default.
• W1999164400 cites W2155942977 @default.
• W1999164400 cites W2161326537 @default.
• W1999164400 cites W2162203216 @default.
• W1999164400 cites W2162508878 @default.
• W1999164400 cites W2165760078 @default.
• W1999164400 cites W2170515647 @default.
• W1999164400 cites W2325815708 @default.
• W1999164400 cites W2609515889 @default.
• W1999164400 cites W4211082074 @default.
• W1999164400 doi "https://doi.org/10.1053/j.seminhematol.2010.11.006" @default.
• W1999164400 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3023940" @default.
• W1999164400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21232655" @default.
• W1999164400 hasPublicationYear "2011" @default.
• W1999164400 type Work @default.
• W1999164400 sameAs 1999164400 @default.
• W1999164400 citedByCount "22" @default.
• W1999164400 countsByYear W19991644002012 @default.
• W1999164400 countsByYear W19991644002013 @default.
• W1999164400 countsByYear W19991644002014 @default.
• W1999164400 countsByYear W19991644002015 @default.
• W1999164400 countsByYear W19991644002016 @default.
• W1999164400 countsByYear W19991644002017 @default.
• W1999164400 countsByYear W19991644002018 @default.
• W1999164400 countsByYear W19991644002020 @default.
• W1999164400 countsByYear W19991644002021 @default.
• W1999164400 countsByYear W19991644002022 @default.
• W1999164400 crossrefType "journal-article" @default.
• W1999164400 hasAuthorship W1999164400A5000683497 @default.
• W1999164400 hasAuthorship W1999164400A5058021865 @default.
• W1999164400 hasAuthorship W1999164400A5067251812 @default.
• W1999164400 hasAuthorship W1999164400A5082004555 @default.
• W1999164400 hasAuthorship W1999164400A5082080836 @default.
• W1999164400 hasBestOaLocation W19991644002 @default.
• W1999164400 hasConcept C118220434 @default.
• W1999164400 hasConcept C126322002 @default.
• W1999164400 hasConcept C126838900 @default.
• W1999164400 hasConcept C142724271 @default.
• W1999164400 hasConcept C143409427 @default.
• W1999164400 hasConcept C159654299 @default.
• W1999164400 hasConcept C163864487 @default.
• W1999164400 hasConcept C203014093 @default.
• W1999164400 hasConcept C2775842073 @default.
• W1999164400 hasConcept C2776169692 @default.
• W1999164400 hasConcept C2776364478 @default.
• W1999164400 hasConcept C2776541429 @default.
• W1999164400 hasConcept C2777250017 @default.
• W1999164400 hasConcept C2780007613 @default.
• W1999164400 hasConcept C31601959 @default.
• W1999164400 hasConcept C542903549 @default.
• W1999164400 hasConcept C71924100 @default.
• W1999164400 hasConceptScore W1999164400C118220434 @default.

• next